查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1701348

聽力損失治療市場規模、佔有率、趨勢分析報告：按產品、疾病、最終用途、地區、細分市場預測，2025-2030 年

Hearing Loss Disease Treatment Market Size, Share & Trends Analysis Report By Product (Devices, Drugs), By Disease (Conductive, Sensorineural), By End Use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

聽力損失治療市場的成長與趨勢：

根據Grand View Research, Inc.的最新報告，全球聽力損失治療市場規模預計到2030年將達到175.1億美元，2025年至2030年期間的複合年成長率為7.29%。

這種成長的推動因素包括全球疾病負擔的增加、政府和私人組織為提高意識所做的努力以及世界老年人口的不斷成長。此外，臨床研發藥物數量的增加和助聽設備的進步為該行業的發展提供了有利的機會。全球聽力損失的盛行率正在上升，這是推動該行業成長的主要因素。

例如，世界衛生組織報告稱，到2021年，全球將有超過5%的人口（約4.3億人）需要復健治療來控制聽力損失。此外，預計到2050年，全球約有25億人將受到聽力損失的影響。報告稱，中低收入國家佔殘障人口的80%。老化進一步加劇了盛行率的上升。在全球整體，大約有25%的60歲以上的老人患有聽力損失。因此，疾病的增加透過增加治療需求來推動該行業的發展。該領域存在強大的臨床試驗管道，預計在未來幾年提供更好的治療選擇。

這是由於目前有超過 45 種治療方法處於不同階段的臨床試驗。例如，Sound Pharmaceuticals 的 Ebselen 和 Sensorion 的 SENS-401 分別處於治療梅尼爾氏症和感音性聽障的 3 期臨床試驗階段。同樣，2022 年 6 月，Pipeline Therapeutics 的 2 期研究藥物 PIPE-505 正在接受感音性聽障的評估。因此，未來幾年新治療方案的推出預計將為該行業提供豐厚的機會。不斷湧現的技術進步，例如聽力產品中與人工智慧相關的創新，正在推動該行業的發展。

推出具有智慧型手機操作、可充電和防水設備等先進功能的產品正在提升客戶體驗。例如，2022 年 6 月，GN Hearing 推出了“Custom made by Resound”，這是一款可充電助聽器，支援 Android 和 iOS 的無線串流播放。主要企業正在採取新產品發布、合作夥伴關係、協議和金融投資等策略性舉措，進一步推動產業發展。例如，2022 年 4 月，Autigen 與勃林格殷格翰達成研究合作和授權合約，為患有感音神經疾病的患者開發先進的治療方法。同樣，2022 年 9 月，Fennec Pharmaceuticals 宣布 FDA核准Pedmarkto 用於預防接受化療的兒科患者的聽力損失。

聽力損失治療市場報告重點：

  • 2024年，設備部門佔據產業主導地位，佔總收益的最大佔有率，超過91.02％。這是由於設備技術的進步、其普及率高以及設備效益的不斷提高。
  • 由於新治療產品的推出，預計預測期內製藥業將實現最快的複合年成長率。有多種類型的聽力損失可以使用藥物治療。
  • 預計到 2024 年，感音性聽障領域將佔據行業主導地位，佔總收入的最大佔有率，超過 65.24%，並且預計將成為預測期內成長最快的領域。
  • 2024年，北美聽力損失治療產業佔據全球主導地位，佔全球佔有率的31.32%。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章聽力損​​失治療市場變數、趨勢和範圍

  • 市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 社會恥辱的存在
  • 中低收入國家（LMIC）的報銷制度不足
  • 商業環境分析
    • 產業分析-波特五力分析
    • PESTLE分析
    • 管道分析

第4章聽力損失治療市場：按產品分類的業務分析

  • 2024 年及 2030 年產品市場佔有率
  • 產品細分儀表板
  • 市場規模、預測與趨勢分析（按產品，2018-2030 年）
  • 裝置
  • 藥物

第5章聽力損失治療市場：依疾病的商業分析

  • 2024年及2030年的疾病市場佔有率
  • 疾病細分儀表板
  • 市場規模、預測與趨勢分析（按疾病，2018-2030 年）
  • 傳導性聽力損失
  • 感覺神經性聽力損失
  • 混合型（傳導性和感音神經性）

第6章聽力損失治療市場：最終使用者的商業分析

  • 2024 年及 2030 年最終用戶市場佔有率
  • 最終用戶細分儀表板
  • 按最終用途分類的市場規模、預測和趨勢分析（2018-2030 年）
  • 醫院
  • 耳鼻喉診所
  • 門診

第7章聽力損失治療市場：區域估計和趨勢分析

  • 2024 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 2018年至2030年市場規模與預測趨勢分析：
  • 北美洲
    • 2018-2030年各國情況
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章競爭格局

  • 參與者概述
  • 企業市場分析
  • 公司分類
  • 戰略地圖
  • 公司簡介/列表
    • Novartis AG
    • Spiral Therapeutics（Otonomy, Inc.）
    • Acousia Therapeutics Gmbh
    • Sensorion
    • Audina Hearing Instruments, Inc.
    • Ws Audiology A/S
    • audifon Gmbh &Co. Kg
    • MED-EL Medical Electronics
    • Demant A/S
    • Sonova
Product Code: GVR-4-68040-019-9

Hearing Loss Disease Treatment Market Growth & Trends:

The global hearing loss disease treatment market size is expected to reach USD 17.51 billion by 2030, registering a CAGR of 7.29% from 2025 to 2030, according to a new report by Grand View Research, Inc. The growth is attributed to the global rise in disease burden, initiatives undertaken by government and private organizations to spread awareness among people, and the growing geriatric population in the world. Furthermore, the increasing number of clinical pipeline drugs and advancements with auditory devices offer lucrative opportunities for industry growth. The world is witnessing an increasing prevalence of hearing loss cases, which is the key factor driving the industry's growth.

For instance, according to the WHO reports, in 2021, over 5% of the world's population, or around 430 million people, require rehabilitation to manage their listening disability. Moreover, by 2050, nearly 2.5 billion people are estimated to be impacted by listening impairment across the globe. As per the report, low- and middle-income countries account for 80% of people suffering from a disability. Aging has further led to an increase in the prevalence of the disease. Globally, approximately 25% of people aged 60 years are affected by hearing loss. Therefore, the rising disease cases increase the demand for treatment and drive the space. The space has the presence of a robust clinical trial pipeline, which is expected to offer better treatment options in the coming years.

This can be anticipated due to the presence of more than 45 therapies at different phases of clinical investigation. For instance, Sound Pharmaceuticals' Ebselen and Sensorion's SENS-401 are under phase 3 clinical studies indicated for the treatment of Meniere's Disease and sensorineural hearing loss, respectively. Similarly, in June 2022, Pipeline Therapeutics' phase 2 drug, PIPE-505 is being evaluated for sensorineural hearing loss. Therefore, the launch of new treatment options in the coming years is expected to offer a lucrative opportunity for the industry. Rising technological advancements, such as AI-associated innovations, in auditory products, are boosting the industry.

The launch of products with advanced features like operating through smartphones and rechargeable & waterproof devices is enhancing customer experience. For instance, in June 2022, GN Hearing launched Custom made by Resound, a chargeable hearing aid that supports wireless streaming from Android and iOS. Key players are implementing strategic initiatives, such as new launches, collaborations, agreements, and financial investments, which are further driving the industry. For instance, in April 2022, Autigen entered into a collaboration and licensing agreement with Boehringer Ingelheim to develop advanced therapies for people suffering from sensorineural conditions. Similarly, in September 2022, Fennec Pharmaceuticals announced the FDA approval for Pedmarkto prevents hearing loss in pediatric patients going through chemotherapy.

Hearing Loss Disease Treatment Market Report Highlights:

  • The devices segment dominated the industry in 2024 and accounted for the maximum share of more than 91.02% of the overall revenue. This can be attributed to technological advancements in devices, high prevalence coupled with the rising benefits of devices.
  • The drugs segment is estimated to register the fastest CAGR over the forecast period due to the launch of new therapeutic products. Drugs are available for several types of hearing problems.
  • The sensorineural hearing loss segment dominated the industry in 2024 and accounted for the maximum share of more than 65.24% of the total revenue and is estimated to be the fastest growing segment over the forecast period.
  • North America hearing loss disease treatment industry held the leading position in 2024, accounting for 31.32% of the global share

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Disease
    • 1.2.3. End User
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Hearing Loss Disease Treatment Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increase in the number of patients with hearing loss
      • 3.2.1.2. Strong research and development pipeline
      • 3.2.1.3. Technological advancements in hearing aids
    • 3.2.2. Market Restraint Analysis
  • 3.3. 3.3.1 Presence of social stigmas
  • 3.4. 3.3.2 Poor reimbursement facilities in low- and middle-income countries (LMICs)
  • 3.5. Business Environment Analysis
    • 3.5.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.5.1.1. Supplier Power
      • 3.5.1.2. Buyer Power
      • 3.5.1.3. Substitution Threat
      • 3.5.1.4. Threat of New Entrants
      • 3.5.1.5. Competitive Rivalry
    • 3.5.2. PESTLE Analysis
    • 3.5.3. Pipeline Analysis

Chapter 4. Hearing Loss Disease Treatment Market: Products Business Analysis

  • 4.1. Products Market Share, 2024 & 2030
  • 4.2. Products Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Products, 2018 to 2030 (USD Million)
  • 4.4. Devices
    • 4.4.1. Devices Market, 2018 - 2030 (USD Million)
  • 4.5. Drugs
    • 4.5.1. Drugs Market, 2018 - 2030 (USD Million)
    • 4.5.2. Systemic steroids
      • 4.5.2.1. Systemic steroids Market, 2018 - 2030 (USD Million)
    • 4.5.3. Antiviral medication
      • 4.5.3.1. Antiviral medication Market, 2018 - 2030 (USD Million)
    • 4.5.4. Vasodilators
      • 4.5.4.1. Vasodilators Market, 2018 - 2030 (USD Million)
    • 4.5.5. Others
      • 4.5.5.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Hearing Loss Disease Treatment Market: Disease Business Analysis

  • 5.1. Disease Market Share, 2024 & 2030
  • 5.2. Disease Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Disease, 2018 to 2030 (USD Million)
  • 5.4. Conductive Hearing Loss
    • 5.4.1. Conductive Hearing Loss Market, 2018 - 2030 (USD Million)
  • 5.5. Sensorineural Hearing Loss
    • 5.5.1. Sensorineural Hearing Loss Market, 2018 - 2030 (USD Million)
  • 5.6. Mixed (Conductive and Sensorineural)
    • 5.6.1. Mixed (Conductive and Sensorineural) Market, 2018 - 2030 (USD Million)

Chapter 6. Hearing Loss Disease Treatment Market: End User Business Analysis

  • 6.1. End User Market Share, 2024 & 2030
  • 6.2. End User Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by End User, 2018 to 2030 (USD Million)
  • 6.4. Hospitals
    • 6.4.1. Hospitals Market, 2018 - 2030 (USD Million)
  • 6.5. Otology clinics
    • 6.5.1. Otology clinics Market, 2018 - 2030 (USD Million)
  • 6.6. Ambulatory clinics
    • 6.6.1. Ambulatory clinics Market, 2018 - 2030 (USD Million)

Chapter 7. Hearing Loss Disease Treatment Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 7.4. North America
    • 7.4.1. North America Hearing Loss Disease Treatment Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Target Disease Prevalence
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. Reimbursement Framework
      • 7.4.2.5. U.S. Hearing Loss Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Target Disease Prevalence
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. Reimbursement Framework
      • 7.4.3.5. U.S. Hearing Loss Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Target Disease Prevalence
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. Reimbursement Framework
      • 7.4.4.5. Mexico Hearing Loss Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe Hearing Loss Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Target Disease Prevalence
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Reimbursement Framework
      • 7.5.2.5. UK Hearing Loss Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Target Disease Prevalence
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Reimbursement Framework
      • 7.5.3.5. Germany Hearing Loss Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Target Disease Prevalence
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. Reimbursement Framework
      • 7.5.4.5. France Hearing Loss Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Target Disease Prevalence
      • 7.5.5.3. Regulatory Framework
      • 7.5.5.4. Reimbursement Framework
      • 7.5.5.5. Italy Hearing Loss Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Target Disease Prevalence
      • 7.5.6.3. Regulatory Framework
      • 7.5.6.4. Reimbursement Framework
      • 7.5.6.5. Spain Hearing Loss Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. Denmark
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Target Disease Prevalence
      • 7.5.7.3. Regulatory Framework
      • 7.5.7.4. Reimbursement Framework
      • 7.5.7.5. Denmark Hearing Loss Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.8. Sweden
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Target Disease Prevalence
      • 7.5.8.3. Regulatory Framework
      • 7.5.8.4. Reimbursement Framework
      • 7.5.8.5. Sweden Hearing Loss Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.9. Norway
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Target Disease Prevalence
      • 7.5.9.3. Regulatory Framework
      • 7.5.9.4. Reimbursement Framework
      • 7.5.9.5. Norway Hearing Loss Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Hearing Loss Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Target Disease Prevalence
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Reimbursement Framework
      • 7.6.2.5. Japan Hearing Loss Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Target Disease Prevalence
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Reimbursement Framework
      • 7.6.3.5. China Hearing Loss Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Target Disease Prevalence
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. Reimbursement Framework
      • 7.6.4.5. India Hearing Loss Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. Australia
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Target Disease Prevalence
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Reimbursement Framework
      • 7.6.5.5. Australia Hearing Loss Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.6. South Korea
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Target Disease Prevalence
      • 7.6.6.3. Regulatory Framework
      • 7.6.6.4. Reimbursement Framework
      • 7.6.6.5. South Korea Hearing Loss Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Target Disease Prevalence
      • 7.6.7.3. Regulatory Framework
      • 7.6.7.4. Reimbursement Framework
      • 7.6.7.5. Thailand Hearing Loss Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Hearing Loss Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Target Disease Prevalence
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. Reimbursement Framework
      • 7.7.2.5. Japan Hearing Loss Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Target Disease Prevalence
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Reimbursement Framework
      • 7.7.3.5. China Hearing Loss Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8. Middle East and Africa
    • 7.8.1. Middle East and Africa Hearing Loss Disease Treatment Market Estimates and Forecasts, 2017 - 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Target Disease Prevalence
      • 7.8.2.3. Regulatory Framework
      • 7.8.2.4. Reimbursement Framework
      • 7.8.2.5. South Africa Hearing Loss Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Target Disease Prevalence
      • 7.8.3.3. Regulatory Framework
      • 7.8.3.4. Reimbursement Framework
      • 7.8.3.5. Saudi Arabia Hearing Loss Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Target Disease Prevalence
      • 7.8.4.3. Regulatory Framework
      • 7.8.4.4. Reimbursement Framework
      • 7.8.4.5. UAE Hearing Loss Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Target Disease Prevalence
      • 7.8.5.3. Regulatory Framework
      • 7.8.5.4. Reimbursement Framework
      • 7.8.5.5. Kuwait Hearing Loss Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Overview
  • 8.2. Company Market Position Analysis
  • 8.3. Company Categorization
  • 8.4. Strategy Mapping
  • 8.5. Company Profiles/Listing
    • 8.5.1. Novartis AG
      • 8.5.1.1. Overview
      • 8.5.1.2. Financial Performance
      • 8.5.1.3. Product Benchmarking
      • 8.5.1.4. Strategic Initiatives
    • 8.5.2. Spiral Therapeutics (Otonomy, Inc.)
      • 8.5.2.1. Overview
      • 8.5.2.2. Financial Performance
      • 8.5.2.3. Product Benchmarking
      • 8.5.2.4. Strategic Initiatives
    • 8.5.3. Acousia Therapeutics Gmbh
      • 8.5.3.1. Overview
      • 8.5.3.2. Financial Performance
      • 8.5.3.3. Product Benchmarking
      • 8.5.3.4. Strategic Initiatives
    • 8.5.4. Sensorion
      • 8.5.4.1. Overview
      • 8.5.4.2. Financial Performance
      • 8.5.4.3. Product Benchmarking
      • 8.5.4.4. Strategic Initiatives
    • 8.5.5. Audina Hearing Instruments, Inc.
      • 8.5.5.1. Overview
      • 8.5.5.2. Financial Performance
      • 8.5.5.3. Product Benchmarking
      • 8.5.5.4. Strategic Initiatives
    • 8.5.6. Ws Audiology A/S
      • 8.5.6.1. Overview
      • 8.5.6.2. Financial Performance
      • 8.5.6.3. Product Benchmarking
      • 8.5.6.4. Strategic Initiatives
    • 8.5.7. audifon Gmbh & Co. Kg
      • 8.5.7.1. Overview
      • 8.5.7.2. Financial Performance
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Strategic Initiatives
    • 8.5.8. MED-EL Medical Electronics
      • 8.5.8.1. Overview
      • 8.5.8.2. Financial Performance
      • 8.5.8.3. Product Benchmarking
      • 8.5.8.4. Strategic Initiatives
    • 8.5.9. Demant A/S
      • 8.5.9.1. Overview
      • 8.5.9.2. Financial Performance
      • 8.5.9.3. Product Benchmarking
      • 8.5.9.4. Strategic Initiatives
    • 8.5.10. Sonova
      • 8.5.10.1. Overview
      • 8.5.10.2. Financial Performance
      • 8.5.10.3. Product Benchmarking
      • 8.5.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviation
  • Table 3 List of Parameters
  • Table 4 List of Distributors
  • Table 5 Global Hearing Loss Disease Treatment Market, By Region, 2018 - 2030 (USD Million)
  • Table 6 Global Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
  • Table 7 Global Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • Table 8 Global Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)
  • Table 9 North America Hearing Loss Disease Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 10 North America Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
  • Table 11 North America Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • Table 12 North America Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)
  • Table 13 U.S. Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
  • Table 14 U.S. Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • Table 15 U.S. Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)
  • Table 16 Canada Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
  • Table 17 Canada Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • Table 18 Canada Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)
  • Table 19 Mexico Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
  • Table 20 Mexico Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • Table 21 Mexico Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)
  • Table 22 Europe Hearing Loss Disease Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 23 Europe Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
  • Table 24 Europe Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • Table 25 Europe Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)
  • Table 26 Germany Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
  • Table 27 Germany Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • Table 28 Germany Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)
  • Table 29 UK Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
  • Table 30 UK Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • Table 31 UK Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)
  • Table 32 France Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
  • Table 33 France Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • Table 34 France Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)
  • Table 35 Italy Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
  • Table 36 Italy Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • Table 37 Italy Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)
  • Table 38 Spain Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
  • Table 39 Spain Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • Table 40 Spain Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)
  • Table 41 Denmark Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
  • Table 42 Denmark Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • Table 43 Denmark Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)
  • Table 44 Sweden Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
  • Table 45 Sweden Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • Table 46 Sweden Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)
  • Table 47 Norway Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
  • Table 48 Norway Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • Table 49 Norway Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific Hearing Loss Disease Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 51 Asia Pacific Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
  • Table 52 Asia Pacific Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • Table 53 Asia Pacific Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)
  • Table 54 Japan Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
  • Table 55 Japan Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • Table 56 Japan Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)
  • Table 57 China Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
  • Table 58 China Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • Table 59 China Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)
  • Table 60 India Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
  • Table 61 India Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • Table 62 India Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)
  • Table 63 South Korea Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
  • Table 64 South Korea Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • Table 65 South Korea Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)
  • Table 66 Australia Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
  • Table 67 Australia Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • Table 68 Australia Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)
  • Table 69 Thailand Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
  • Table 70 Thailand Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • Table 71 Thailand Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)
  • Table 72 Latin America Hearing Loss Disease Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 73 Latin America Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
  • Table 74 Latin America Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • Table 75 Latin America Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)
  • Table 76 Brazil Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
  • Table 77 Brazil Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • Table 78 Brazil Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)
  • Table 79 Argentina Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
  • Table 80 Argentina Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • Table 81 Argentina Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa Hearing Loss Disease Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 83 Middle East & Africa Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
  • Table 84 Middle East & Africa Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • Table 85 Middle East & Africa Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)
  • Table 89 South Africa Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
  • Table 90 South Africa Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • Table 91 South Africa Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)
  • Table 92 UAE Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
  • Table 93 UAE Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • Table 94 UAE Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)
  • Table 95 Kuwait Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
  • Table 96 Kuwait Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • Table 97 Kuwait Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market summary
  • Fig. 8 Market trends & outlook
  • Fig. 9 Market segmentation & scope
  • Fig. 10 Market driver relevance analysis (Current & future impact)
  • Fig. 11 Market restraint relevance analysis (Current & future impact)
  • Fig. 12 Penetration & growth prospect mapping
  • Fig. 13 Hearing Loss Disease Treatment Market - PESTLE Analysis
  • Fig. 14 Porter's Five Forces Analysis
  • Fig. 15 Hearing Loss Disease Treatment Market Outlook Key Takeaways
  • Fig. 16 Hearing Loss Disease Treatment Market: Product Movement Analysis
  • Fig. 17 Global Hearing Loss Disease Treatment Market, by Product, 2018 - 2030 (USD Million)
  • Fig. 18 Global Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 19 Global Devices Market, 2018 - 2030 (USD Million)
  • Fig. 20 Global Drugs Market, 2018 - 2030 (USD Million)
  • Fig. 21 Global Systemic Steroids Market, 2018 - 2030 (USD Million)
  • Fig. 22 Global Antiviral Medication Market, 2018 - 2030 (USD Million)
  • Fig. 23 Global Vasodilators Market, 2018 - 2030 (USD Million)
  • Fig. 24 Global Hearing Loss Disease Treatment Market: Disease Movement Analysis
  • Fig. 25 Global Hearing Loss Disease Treatment Market, by Disease, 2018 - 2030 (USD Million)
  • Fig. 26 Global Conductive Hearing Loss Market, 2018 - 2030 (USD Million)
  • Fig. 27 Global Sensorineural Hearing Loss Market, 2018 - 2030 (USD Million)
  • Fig. 28 Global Mixed Hearing Loss Market, 2018 - 2030 (USD Million)
  • Fig. 29 Global Hearing Loss Disease Treatment Market: End-User Movement Analysis
  • Fig. 30 Global Hearing Loss Disease Treatment Market, by End-User, 2018 - 2030 (USD Million)
  • Fig. 31 Global Otology Clinics Market, 2018 - 2030 (USD Million)
  • Fig. 32 Global Hospitals Market, 2018 - 2030 (USD Million)
  • Fig. 33 Global Ambulatory Clinics Market, 2018 - 2030 (USD Million)
  • Fig. 34 Regional Market: Key Takeaways
  • Fig. 35 Hearing Loss Disease Treatment Market Regional Outlook, 2018 & 2030
  • Fig. 36 North America Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 37 U.S. Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 38 Canada Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 39 Mexico Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 40 Europe Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 41 Germany Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 42 UK Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 43 France Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 44 Italy Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 45 Spain Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 46 Denmark Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 47 Sweden Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 48 Norway Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 49 Asia Pacific Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 50 Japan Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 51 China Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 52 India Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 53 South Korea Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 54 Australia Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 55 Thailand Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 56 Latin America Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 57 Brazil Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 58 Argentina Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 59 Middle East & Africa Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 60 South Africa Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 61 Saudi Arabia Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 62 UAE Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 63 Kuwait Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 64 Strategy Frameworks